Ken Fisher

Fisher Asset Management

Kenneth Lawrence Fisher, born in 1950, is a prominent American investment analyst, author, and the founder of Fisher Asset Management. He has made significant contributions to the investment advisory field, particularly through his long-running column in Forbes, which spanned from 1984 to 2017. Fisher is known for his insights into behavioral finance and has authored eleven books on investing. His influence was recognized in 2010 when he was named one of the 30 most influential people in the investment advisory business by Investment Advisor magazine. Fisher Asset Management operates as a fee-only financial adviser, emphasizing a client-centric approach to investment management. The firm is recognized for its strategic focus on diverse sectors, including technology, energy, and healthcare. Fisher's investment philosophy often integrates behavioral finance principles, seeking to capitalize on market inefficiencies and investor psychology. The latest disclosure from Fisher Asset Management, dated May 5, 2026, reveals a balanced approach with both position reductions and increases across a portfolio totaling between $9.6 billion and $5.5 billion. Notable moves include a significant trim of approximately $2.63 billion in Microsoft Corp (MSFT), reflecting a strategic adjustment within a diverse array of holdings that also feature AbbVie Inc. (ABBV), Exxon Mobil Corp (XOM), and Pfizer Inc. (PFE). The firm has made six increases and six reductions, indicating a dynamic portfolio management strategy.

Latest Holdings

HoldingReported ValueWeightSharesLast PriceEst. ValueReturn
BRIDGEBIO PHARMA INCBBIO · Q1 2026$26M0%351.6k$81.46$29M+9.7%
BioCryst Pharmaceuticals, Inc. - Common StockBCRX · Q1 2026$26M0%2.7M$9.11$25M-4.36%
Ligand Pharmaceuticals IncLGND · Q1 2026$26M0%128k$293.99$38M+47.3%
Nutanix IncNTNX · Q1 2026$25M0%670k$54.59$37M+43.6%
AAR Corp.AIR · Q1 2026$25M0%230.6k$137.75$32M+25.8%
Fresh Del Monte Produce Inc.FDP · Q1 2026$25M0%626.2k$29.22$18M-27.4%
Snap-on IncorporatedSNA · Q1 2026$25M0%69k$403.70$28M+11.1%
Texas Capital Bancshares IncTCBI · Q1 2026$24M0%257.4k$103.65$27M+9.24%
74965L10174965L101 · Q1 2026$24M0%3.3M------
Capri Holdings LimitedCPRI · Q1 2026$24M0%1.4M$15.94$22M-9.53%
3.3733E+3063.3733E+306 · Q1 2026$24M0%103.2k------
SiteOne Landscape Supply IncSITE · Q1 2026$24M0%180.7k$104.78$19M-21.3%
Veracyte IncVCYT · Q1 2026$24M0%736.3k$59.22$44M+83.9%
ASTRONICS CORPATRO · Q1 2026$23M0%348.8k$66.04$23M-1.03%
F5 IncFFIV · Q1 2026$23M0%79.7k$403.41$32M+39.4%
V2X, Inc.VVX · Q1 2026$23M0%334.3k$75.05$25M+9.56%
Worthington Industries, Inc.WOR · Q1 2026$23M0%433.6k$53.98$23M+3.53%
Scholar Rock Holding CorporationSRRK · Q1 2026$23M0%458k$51.73$24M+5.23%
First American Financial CorporationFAF · Q1 2026$22M0%371.4k$71.65$27M+18.8%
ProPetro Holding Corp.PUMP · Q1 2026$22M0%1.5M$13.43$20M-6.8%
RENAISSANCERE HOLDINGS LTDRNR · Q1 2026$21M0%71.5k$307.73$22M+3.53%
Steel Dynamics IncSTLD · Q1 2026$21M0%117.4k$235.56$28M+30.9%
Revolution Medicines, Inc.RVMD · Q1 2026$21M0%215.9k$184.44$40M+89.7%
Fluor CorpFLR · Q1 2026$21M0%449.4k$49.51$22M+6.13%
The Health Care Select Sector SPDR FundXLV · Q1 2026$21M0%142.9k$158.29$23M+7.97%
G52694109G52694109 · Q1 2026$21M0%429k------
PTC Inc. - Common StockPTC · Q1 2026$21M0%144.9k$123.61$18M-13.3%
Levi Strauss & Co.LEVI · Q1 2026$21M0%1.1M$23.92$27M+29.4%
United Therapeutics CorporationUTHR · Q1 2026$20M0%34.4k$535.83$18M-9.64%
06652V20806652V208 · Q1 2026$20M0%331.9k------
First Financial Bancorp.FFBC · Q1 2026$20M0%713.5k$36.18$26M+29.8%
State Street SPDR EURO STOXX 50 ETFFEZ · Q1 2026$19M0%311.6k$68.01$21M+9.55%
iShares ESG Aware USD Corporate Bond ETFSUSC · Q1 2026$19M0%832.8k$22.90$19M-1.05%
Lennox International IncLII · Q1 2026$19M0%41.1k$548.67$23M+18.2%
78464A66478464A664 · Q1 2026$19M0%722.8k------
Independence Realty Trust IncIRT · Q1 2026$18M0%1.2M$16.97$21M+14%
Tetra Tech, Inc.TTEK · Q1 2026$18M0%612.6k$31.33$19M+4.02%
Church & Dwight Co., Inc.CHD · Q1 2026$18M0%197.1k$97.79$19M+4.79%
7.4366E+1067.4366E+106 · Q1 2026$18M0%174k------
Berkshire Hathaway Inc.BRK-B · Q1 2026$18M0%38.1k$493.12$19M+2.9%
Vanguard Short-Term Corporate Bond ETFVCSH · Q1 2026$18M0%228.2k$78.71$18M-0.71%
Pure Storage IncP · Q1 2026$18M0%300.6k$70.75$21M+19.8%
Cal-Maine Foods, Inc.CALM · Q1 2026$18M0%223.9k$85.36$19M+7.85%
BXP, Inc.BXP · Q1 2026$17M0%326k$68.94$22M+32.8%
Freshpet, Inc. - Common StockFRPT · Q1 2026$17M0%282k$57.01$16M-3.32%
ACADIA Pharmaceuticals Inc.ACAD · Q1 2026$16M0%732.9k$25.60$19M+15%
Neurocrine Biosciences, Inc.NBIX · Q1 2026$16M0%122.2k$174.08$21M+32.1%
ITT Inc. Common StockITT · Q1 2026$16M0%84.4k$195.34$16M+2.52%
Halliburton CompanyHAL · Q1 2026$16M0%408.1k$33.19$14M-14.9%
Commerce Bancshares, Inc.CBSH · Q1 2026$16M0%320.3k$58.78$19M+19.5%
Showing 301-350 of 1,014